ESC 365 - SGLT2 inhibitors in practice (part 1): what is the state of heart failure treatment in 2022?
2021 ESC guideline on Heart Failure: SGLT2 inhibitors finally entering the centre stage and more.
JCM | Free Full-Text | SGLT2 Inhibitors in Type 2 Diabetes Mellitus and Heart Failure—A Concise Review
AHA 2019 : SGLT2 inhibitors in heart failure | Radcliffe Cardiology
The latest ESC guidelines for glucose lowering agents and CVD -SGLT2i... | Download Scientific Diagram
SOLACI | Latin American Society of Interventional Cardiology
Il diabete di tipo 2 nel paziente anziano - SIPREC
Pharmaceutics | Free Full-Text | The New Role of SGLT2 Inhibitors in the Management of Heart Failure: Current Evidence and Future Perspective
New ESC guideline recommends SGLT2 inhibitors for HFrEF
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control | Nature Reviews Cardiology
ESC 365 - Everything you need to know about SGLT2 inhibitors in heart failure – discussion.
Alfonso Valle on Twitter: "Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD➡️ Treatment algorithm in patients with type 2 diabetes mellitus and atherosclerotic CV disease, or high/very
SGLT‐2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects | Journal of the American Heart Association
ESC 365 - State of the Art - SGLT2 inhibitors in cardiovascular disease
2021 ESC guideline on Heart Failure: SGLT2 inhibitors finally entering the centre stage and more.
SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications - The Lancet
SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: A systematic review and meta-analysis - eClinicalMedicine
Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week - ScienceDirect
Nuove linee guida europee sull'insufficienza cardiaca: SGLT2 inibi
ESC 365 - State of the Art - SGLT2 inhibitors in cardiovascular disease
